日本新薬(株)□企業情報

主市場業種証券コード/EDINET英名称
東証PRM医薬品4516/E00931-

日証金(2024-04-25付)

信用売り残高
0株
前日比
0%
信用買い残高
2万7400株
前日比
-3.52%

□もっと見る

東証(2024-04-19付)

信用売り残高
2万1200株
前週比
-27.15%
信用買い残高
36万8200株
前週比
0.79%

□もっと見る

日証協(2024-04-12付)

貸付残高
74万5012株
前週比
65.61%
貸付新規
40万9740株
前週比
-7.41%

□もっと見る

逆日歩(品貸料)

2023-10-19
2023-10-04
2023-08-31
2023-08-30

□もっと見る

機関の空売り残高情報

計算日空売り者残高割合増減率残高数量増減量備考
2023/08/31Integrated Core Strategies0.030%-1.620%22,700株-1,138,760報告義務消失
2023/08/30Integrated Core Strategies1.650%+0.060%1,161,460株+43,000
2023/08/29Integrated Core Strategies1.590%+0.110%1,118,460株+78,100
2023/08/28Integrated Core Strategies1.480%+0.130%1,040,360株+90,400
2023/08/25Integrated Core Strategies1.350%+0.140%949,960株+98,000
2023/08/21Integrated Core Strategies1.210%+0.100%851,960株+70,500
2023/08/16Integrated Core Strategies1.110%+0.100%781,460株+68,200
2023/08/09Integrated Core Strategies1.010%+0.110%713,260株+76,400
2023/08/04Integrated Core Strategies0.900%+0.080%636,860株+60,500
2023/07/28Integrated Core Strategies0.820%+0.120%576,360株+81,875
2023/07/24Integrated Core Strategies0.700%+0.090%494,485株+63,900
2023/07/18Integrated Core Strategies0.610%+0.110%430,585株+77,900
2023/07/11Integrated Core Strategies0.500%0%352,685株
2022/08/10Citigroup Global Markets ltd0.490%-0.050%347,935株-33,739報告義務消失
2022/07/21Citigroup Global Markets ltd0.540%0%381,674株再IN(前回2022-06-21)
2022/06/21Citigroup Global Markets ltd0.490%-0.010%350,474株-2,400報告義務消失
2022/06/20Citigroup Global Markets ltd0.500%0%352,874株
2019/12/16Perceptive Life Sciences0.420%-0.200%293,900株-139,700報告義務消失
2019/12/10Perceptive Life Sciences0.620%+0.100%433,600株+69,100
2019/12/06Perceptive Life Sciences0.520%0%364,500株
2019/03/28AQR Capital Management0.490%-0.020%350,900株-10,900報告義務消失
2019/01/04AQR Capital Management0.510%0%361,800株

Page Top